367 related articles for article (PubMed ID: 21769075)
1. Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis.
Tursi A; Elisei W; Giorgetti G; Aiello F; Brandimarte G
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):247-55. PubMed ID: 21769075
[TBL] [Abstract][Full Text] [Related]
2. Faecal calprotectin in colonic diverticular disease: a case-control study.
Tursi A; Brandimarte G; Elisei W; Giorgetti GM; Inchingolo CD; Aiello F
Int J Colorectal Dis; 2009 Jan; 24(1):49-55. PubMed ID: 18941760
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
4. Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: a comparison with fecal calprotectin in clinical setting.
Tursi A; Elisei W; Picchio M; Giorgetti GM; Brandimarte G
J Clin Gastroenterol; 2015 Mar; 49(3):218-21. PubMed ID: 24583746
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis down-regulates after treatment.
Tursi A; Elisei W; Brandimarte G; Giorgetti GM; Inchingolo CD; Nenna R; Ierardi E
J Gastrointestin Liver Dis; 2011 Dec; 20(4):365-70. PubMed ID: 22187701
[TBL] [Abstract][Full Text] [Related]
6. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
7. Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.
Garcia-Planella E; Mañosa M; Chaparro M; Beltrán B; Barreiro-de-Acosta M; Gordillo J; Ricart E; Bermejo F; García-Sánchez V; Piqueras M; Llaó J; Gisbert JP; Cabré E; Domènech E;
Scand J Gastroenterol; 2018 Feb; 53(2):152-157. PubMed ID: 29189092
[TBL] [Abstract][Full Text] [Related]
8. Fecal markers: calprotectin and lactoferrin.
Abraham BP; Kane S
Gastroenterol Clin North Am; 2012 Jun; 41(2):483-95. PubMed ID: 22500530
[TBL] [Abstract][Full Text] [Related]
9. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K
J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960
[TBL] [Abstract][Full Text] [Related]
10. Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study.
Tursi A; Elisei W; Brandimarte G; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E
Neurogastroenterol Motil; 2012 Sep; 24(9):836-e396. PubMed ID: 22680042
[TBL] [Abstract][Full Text] [Related]
11. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of four fecal assays in the diagnosis of colitis.
Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
[TBL] [Abstract][Full Text] [Related]
13. Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity.
Tursi A; Elisei W; Brandimarte G; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E
Colorectal Dis; 2012 May; 14(5):e258-63. PubMed ID: 22469482
[TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
Caviglia GP; Pantaleoni S; Touscoz GA; Adriani A; Rosso C; Smedile A; Pellicano R; Astegiano M; Bresso F
Scand J Gastroenterol; 2014 Dec; 49(12):1419-24. PubMed ID: 25369978
[TBL] [Abstract][Full Text] [Related]
15. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.
Elkjaer M
Dan Med J; 2012 Jul; 59(7):B4478. PubMed ID: 22759851
[TBL] [Abstract][Full Text] [Related]
16. Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.
Annaházi A; Molnár T; Farkas K; Rosztóczy A; Izbéki F; Gecse K; Inczefi O; Nagy F; Földesi I; Szűcs M; Dabek M; Ferrier L; Theodorou V; Bueno L; Wittmann T; Róka R
Inflamm Bowel Dis; 2013 Feb; 19(2):316-20. PubMed ID: 22550024
[TBL] [Abstract][Full Text] [Related]
17. Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome.
Sprakes MB; Hamlin PJ; Ford AC
Am J Gastroenterol; 2011 Jan; 106(1):166; author reply 166-7. PubMed ID: 21212757
[No Abstract] [Full Text] [Related]
18. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment.
Theede K; Kiszka-Kanowitz M; Nielsen AM; Nordgaard-Lassen I
Scand J Gastroenterol; 2014 Apr; 49(4):418-23. PubMed ID: 24495103
[TBL] [Abstract][Full Text] [Related]
19. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?
Keohane J; O'Mahony C; O'Mahony L; O'Mahony S; Quigley EM; Shanahan F
Am J Gastroenterol; 2010 Aug; 105(8):1788, 1789-94; quiz 1795. PubMed ID: 20389294
[TBL] [Abstract][Full Text] [Related]
20. The semi-quantitative calprotectin rapid test--is it useful in inflammatory bowel disease?
Dranga M; Dumitrescu G; Badea M; Blaj A; Mihai C; Prelipcean CC
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):761-5. PubMed ID: 23272524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
